Clinical Trials Directory

Trials / Conditions / NK-LGL Leukemia

NK-LGL Leukemia

5 registered clinical trials studyying NK-LGL Leukemia — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingJAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06716658
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingPI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06530550
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingThalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
NCT06530576
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingRegistry of the German CLL Study Group
NCT02863692
German CLL Study Group—
RecruitingNational Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766
Institute of Hematology & Blood Diseases Hospital, China—